R.R. Bunge

992 total citations
14 papers, 687 citations indexed

About

R.R. Bunge is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, R.R. Bunge has authored 14 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in R.R. Bunge's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). R.R. Bunge is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Pulmonary Hypertension Research and Treatments (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). R.R. Bunge collaborates with scholars based in United States, Canada and Bulgaria. R.R. Bunge's co-authors include Brian A. Bruckner, Luis J. Garcia‐Morales, Harry Karmouty‐Quintana, Tingting Weng, Matthias Loebe, Michael R. Blackburn, Fayong Luo, Jose G. Molina, Ernestina Melicoff and Kemly Philip and has published in prestigious journals such as JAMA, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

R.R. Bunge

14 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.R. Bunge United States 10 306 266 91 80 60 14 687
Luis J. Garcia‐Morales United States 7 309 1.0× 71 0.3× 90 1.0× 90 1.1× 60 1.0× 11 492
Irfan I. Galaria United States 14 257 0.8× 82 0.3× 92 1.0× 147 1.8× 43 0.7× 23 526
Yoh Arita Japan 10 245 0.8× 110 0.4× 124 1.4× 87 1.1× 60 1.0× 36 456
Leonard A. Arbeit United States 13 106 0.3× 112 0.4× 88 1.0× 55 0.7× 56 0.9× 19 551
Kelley L. Colvin United States 15 460 1.5× 228 0.9× 138 1.5× 115 1.4× 84 1.4× 26 702
Karl‐Otto Larsen Norway 10 174 0.6× 92 0.3× 162 1.8× 54 0.7× 47 0.8× 14 354
Tetsunori Ishikawa Japan 12 68 0.2× 221 0.8× 54 0.6× 149 1.9× 79 1.3× 34 451
Thilo Witsch Germany 10 99 0.3× 105 0.4× 165 1.8× 43 0.5× 305 5.1× 18 509
Marie Chaix Canada 15 133 0.4× 239 0.9× 155 1.7× 80 1.0× 71 1.2× 41 581
Yi-Chun Xu-Dubois France 16 103 0.3× 48 0.2× 189 2.1× 209 2.6× 48 0.8× 28 631

Countries citing papers authored by R.R. Bunge

Since Specialization
Citations

This map shows the geographic impact of R.R. Bunge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.R. Bunge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.R. Bunge more than expected).

Fields of papers citing papers by R.R. Bunge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.R. Bunge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.R. Bunge. The network helps show where R.R. Bunge may publish in the future.

Co-authorship network of co-authors of R.R. Bunge

This figure shows the co-authorship network connecting the top 25 collaborators of R.R. Bunge. A scholar is included among the top collaborators of R.R. Bunge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.R. Bunge. R.R. Bunge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Valderrábano, Miguel, L. E. Peterson, Vijay Swarup, et al.. (2020). Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation. JAMA. 324(16). 1620–1620. 172 indexed citations
3.
Valderrábano, Miguel, L. E. Peterson, R.R. Bunge, et al.. (2019). Vein of Marshall ethanol infusion for persistent atrial fibrillation: VENUS and MARS clinical trial design. American Heart Journal. 215. 52–61. 13 indexed citations
4.
Chen, Ning-Yuan, Scott D. Collum, Fayong Luo, et al.. (2016). Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 311(2). L238–L254. 66 indexed citations
5.
Garcia‐Morales, Luis J., Ning-Yuan Chen, Tingting Weng, et al.. (2015). Altered Hypoxic–Adenosine Axis and Metabolism in Group III Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 54(4). 574–583. 34 indexed citations
6.
Weng, Tingting, Jens M. Poth, Harry Karmouty‐Quintana, et al.. (2014). Hypoxia-induced Deoxycytidine Kinase Contributes to Epithelial Proliferation in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 190(12). 1402–1412. 44 indexed citations
7.
Bruckner, Brian A., Limael E. Rodríguez, R.R. Bunge, et al.. (2014). Large Cardiac Tumor Managed With Resection and Two Ventricular Assist Devices. The Annals of Thoracic Surgery. 97(1). 321–324. 11 indexed citations
8.
Karmouty‐Quintana, Harry, Ernestina Melicoff, Tingting Weng, et al.. (2014). Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis. The Journal of Immunology. 193(7). 3755–3768. 235 indexed citations
9.
Karmouty‐Quintana, Harry, Tingting Weng, Luis J. Garcia‐Morales, et al.. (2013). Adenosine A2B Receptor and Hyaluronan Modulate Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 49(6). 1038–1047. 50 indexed citations
10.
Bruckner, Brian A., Tadashi Motomura, Thomas Kaleekal, et al.. (2013). Clinical Outcomes in Elderly Lung Transplant Recipients 70 Years and Older. The Journal of Heart and Lung Transplantation. 32(4). S266–S267. 1 indexed citations
11.
Weng, Tingting, Harry Karmouty‐Quintana, Luis J. Garcia‐Morales, et al.. (2013). Hypoxia‐induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease. The FASEB Journal. 27(5). 2013–2026. 15 indexed citations
12.
Bunge, R.R., Amit Patel, Baron L. Hamman, et al.. (2012). 192 Safety and Efficacy of Ixmyelocel-T, an Expanded Patient-Specific Mixed Cell Product, in Dilated Cardiomyopathy (IMPACT-DCM). The Journal of Heart and Lung Transplantation. 31(4). S72–S73. 1 indexed citations
13.
Bruckner, Brian A., Matthias Loebe, Jerry D. Estep, et al.. (2012). 784 Clinical Experience with Patients over Age 65 Who Undergo HeartMate II LVAD Placement for Destination Therapy. The Journal of Heart and Lung Transplantation. 31(4). S267–S267. 1 indexed citations
14.
Motomura, Tadashi, et al.. (2011). Superior Mesenteric Artery Mycotic Aneurysm in Patients With Left Ventricular Assist Device Support and Intravenous Drug Abuse. Artificial Organs. 35(7). E164–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026